HNRNPF | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
endothelial cell	39 studies	40% ± 17%	Explore
natural killer cell	38 studies	44% ± 14%	Explore
B cell	37 studies	39% ± 13%	Explore
fibroblast	37 studies	34% ± 13%	Explore
CD8-positive, alpha-beta T cell	35 studies	45% ± 18%	Explore
macrophage	34 studies	33% ± 12%	Explore
T cell	32 studies	41% ± 16%	Explore
CD4-positive, alpha-beta T cell	32 studies	45% ± 18%	Explore
pericyte	27 studies	37% ± 13%	Explore
conventional dendritic cell	27 studies	41% ± 13%	Explore
smooth muscle cell	25 studies	32% ± 10%	Explore
regulatory T cell	25 studies	46% ± 17%	Explore
non-classical monocyte	23 studies	38% ± 12%	Explore
classical monocyte	22 studies	34% ± 11%	Explore
basal cell	21 studies	42% ± 15%	Explore
epithelial cell	21 studies	43% ± 19%	Explore
mature NK T cell	20 studies	39% ± 12%	Explore
mast cell	19 studies	29% ± 12%	Explore
monocyte	19 studies	34% ± 12%	Explore
memory B cell	19 studies	38% ± 12%	Explore
plasmacytoid dendritic cell	19 studies	31% ± 11%	Explore
dendritic cell	18 studies	39% ± 22%	Explore
ciliated cell	18 studies	59% ± 20%	Explore
naive B cell	17 studies	33% ± 10%	Explore
gamma-delta T cell	17 studies	43% ± 14%	Explore
endothelial cell of lymphatic vessel	16 studies	35% ± 12%	Explore
CD16-negative, CD56-bright natural killer cell, human	15 studies	38% ± 14%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	15 studies	36% ± 10%	Explore
connective tissue cell	15 studies	40% ± 8%	Explore
CD16-positive, CD56-dim natural killer cell, human	14 studies	42% ± 13%	Explore
mucosal invariant T cell	14 studies	36% ± 12%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	13 studies	39% ± 14%	Explore
myeloid cell	13 studies	35% ± 15%	Explore
plasma cell	12 studies	37% ± 16%	Explore
CD8-positive, alpha-beta memory T cell	12 studies	44% ± 17%	Explore
capillary endothelial cell	12 studies	38% ± 15%	Explore
myofibroblast cell	12 studies	39% ± 13%	Explore
vein endothelial cell	12 studies	39% ± 12%	Explore
endothelial cell of vascular tree	12 studies	47% ± 16%	Explore
secretory cell	11 studies	35% ± 11%	Explore
plasmablast	10 studies	41% ± 21%	Explore
CD4-positive, alpha-beta memory T cell	10 studies	45% ± 18%	Explore
effector memory CD8-positive, alpha-beta T cell	10 studies	40% ± 12%	Explore
abnormal cell	10 studies	39% ± 12%	Explore
endothelial cell of artery	10 studies	38% ± 9%	Explore
goblet cell	10 studies	33% ± 13%	Explore
type I pneumocyte	9 studies	32% ± 13%	Explore
type II pneumocyte	9 studies	29% ± 14%	Explore
leukocyte	9 studies	36% ± 16%	Explore
club cell	8 studies	32% ± 12%	Explore
effector CD8-positive, alpha-beta T cell	8 studies	46% ± 22%	Explore
progenitor cell	8 studies	46% ± 10%	Explore
mesothelial cell	8 studies	36% ± 17%	Explore
T follicular helper cell	8 studies	45% ± 7%	Explore
retinal rod cell	8 studies	31% ± 18%	Explore
epithelial cell of proximal tubule	7 studies	26% ± 10%	Explore
enterocyte	7 studies	26% ± 9%	Explore
innate lymphoid cell	7 studies	38% ± 8%	Explore
respiratory goblet cell	6 studies	31% ± 17%	Explore
effector CD4-positive, alpha-beta T cell	6 studies	55% ± 22%	Explore
mononuclear phagocyte	6 studies	41% ± 19%	Explore
kidney loop of Henle epithelial cell	6 studies	22% ± 5%	Explore
renal alpha-intercalated cell	6 studies	39% ± 4%	Explore
transit amplifying cell	6 studies	39% ± 13%	Explore
hematopoietic stem cell	6 studies	40% ± 17%	Explore
precursor B cell	6 studies	44% ± 14%	Explore
microglial cell	6 studies	29% ± 8%	Explore
effector memory CD4-positive, alpha-beta T cell	6 studies	50% ± 17%	Explore
CD4-positive helper T cell	5 studies	32% ± 14%	Explore
hematopoietic precursor cell	5 studies	52% ± 17%	Explore
exhausted T cell	5 studies	57% ± 10%	Explore
neutrophil	5 studies	18% ± 4%	Explore
erythroblast	5 studies	49% ± 24%	Explore
lymphocyte	5 studies	43% ± 17%	Explore
pro-B cell	5 studies	49% ± 9%	Explore
T-helper 17 cell	5 studies	56% ± 21%	Explore
neuron	5 studies	36% ± 15%	Explore
alveolar macrophage	5 studies	27% ± 2%	Explore
granulocyte	5 studies	30% ± 10%	Explore
oligodendrocyte precursor cell	5 studies	29% ± 7%	Explore
deuterosomal cell	4 studies	48% ± 10%	Explore
platelet	4 studies	19% ± 1%	Explore
pancreatic A cell	4 studies	39% ± 9%	Explore
enteroendocrine cell	4 studies	43% ± 9%	Explore
intestinal crypt stem cell	4 studies	35% ± 8%	Explore
megakaryocyte	4 studies	35% ± 5%	Explore
brush cell	4 studies	29% ± 18%	Explore
immature B cell	4 studies	50% ± 14%	Explore
astrocyte	4 studies	30% ± 10%	Explore
retina horizontal cell	4 studies	24% ± 12%	Explore
adventitial cell	4 studies	32% ± 14%	Explore
germinal center B cell	4 studies	44% ± 15%	Explore
luminal hormone-sensing cell of mammary gland	4 studies	58% ± 7%	Explore
hepatocyte	4 studies	44% ± 21%	Explore
erythrocyte	4 studies	51% ± 26%	Explore
oligodendrocyte	4 studies	21% ± 4%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	4 studies	40% ± 13%	Explore
double negative thymocyte	4 studies	47% ± 18%	Explore
duct epithelial cell	3 studies	20% ± 6%	Explore
ionocyte	3 studies	32% ± 10%	Explore
precursor cell	3 studies	60% ± 3%	Explore
squamous epithelial cell	3 studies	44% ± 25%	Explore
type B pancreatic cell	3 studies	38% ± 7%	Explore
glomerular endothelial cell	3 studies	22% ± 2%	Explore
kidney distal convoluted tubule epithelial cell	3 studies	45% ± 19%	Explore
neural crest cell	3 studies	49% ± 13%	Explore
retinal ganglion cell	3 studies	30% ± 10%	Explore
extravillous trophoblast	3 studies	44% ± 16%	Explore
placental villous trophoblast	3 studies	49% ± 16%	Explore
retinal cone cell	3 studies	43% ± 16%	Explore
retinal pigment epithelial cell	3 studies	33% ± 18%	Explore
serous secreting cell	3 studies	25% ± 13%	Explore
tissue-resident macrophage	3 studies	31% ± 8%	Explore
intraepithelial lymphocyte	3 studies	45% ± 13%	Explore
Mueller cell	3 studies	28% ± 6%	Explore
intermediate monocyte	3 studies	51% ± 21%	Explore
inflammatory macrophage	3 studies	25% ± 5%	Explore
luminal cell of prostate epithelium	3 studies	32% ± 9%	Explore
muscle cell	3 studies	35% ± 10%	Explore
pancreatic ductal cell	3 studies	57% ± 12%	Explore
megakaryocyte-erythroid progenitor cell	3 studies	52% ± 26%	Explore
glial cell	3 studies	41% ± 24%	Explore
group 3 innate lymphoid cell	3 studies	51% ± 13%	Explore
melanocyte	3 studies	32% ± 13%	Explore
keratinocyte	3 studies	40% ± 9%	Explore
T-helper 1 cell	3 studies	57% ± 9%	Explore
central memory CD4-positive, alpha-beta T cell	3 studies	42% ± 12%	Explore
central memory CD8-positive, alpha-beta T cell	3 studies	40% ± 14%	Explore
progenitor cell of mammary luminal epithelium	3 studies	40% ± 8%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
lung	19 studies	37% ± 12%	Explore
peripheral blood	18 studies	37% ± 12%	Explore
intestine	11 studies	32% ± 14%	Explore
kidney	9 studies	31% ± 11%	Explore
liver	8 studies	33% ± 21%	Explore
eye	7 studies	34% ± 16%	Explore
brain	7 studies	24% ± 5%	Explore
lymph node	6 studies	41% ± 13%	Explore
bone marrow	5 studies	28% ± 10%	Explore
uterus	5 studies	45% ± 15%	Explore
pancreas	4 studies	37% ± 10%	Explore
prostate	4 studies	37% ± 12%	Explore
breast	4 studies	44% ± 3%	Explore
placenta	3 studies	45% ± 11%	Explore
adrenal gland	3 studies	35% ± 14%	Explore
esophagus	3 studies	41% ± 28%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
esophagus	100%	9298.42	1445 / 1445	100%	261.45	183 / 183
intestine	100%	10192.79	966 / 966	100%	330.02	527 / 527
lung	100%	10184.86	578 / 578	100%	264.89	1155 / 1155
stomach	100%	7834.04	359 / 359	100%	299.37	286 / 286
breast	100%	10138.76	459 / 459	100%	367.30	1117 / 1118
prostate	100%	7751.08	245 / 245	100%	308.41	501 / 502
uterus	100%	7830.45	170 / 170	100%	312.66	458 / 459
ovary	100%	8873.56	180 / 180	100%	212.75	429 / 430
bladder	100%	9634.38	21 / 21	100%	313.47	502 / 504
skin	100%	12403.30	1809 / 1809	99%	219.84	468 / 472
thymus	100%	7285.62	652 / 653	99%	203.46	599 / 605
liver	100%	7638.46	226 / 226	98%	167.99	399 / 406
pancreas	98%	4981.29	322 / 328	99%	227.86	177 / 178
kidney	100%	7351.78	89 / 89	98%	156.20	879 / 901
brain	97%	3258.30	2559 / 2642	99%	133.83	699 / 705
adrenal gland	100%	7845.44	258 / 258	89%	92.89	205 / 230
adipose	100%	10518.46	1204 / 1204	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	355.30	29 / 29
spleen	100%	10900.71	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	311.81	45 / 45
ureter	0%	0	0 / 0	100%	123.83	1 / 1
blood vessel	100%	6856.57	1334 / 1335	0%	0	0 / 0
muscle	99%	5510.39	798 / 803	0%	0	0 / 0
peripheral blood	99%	10356.06	916 / 929	0%	0	0 / 0
eye	0%	0	0 / 0	98%	182.19	78 / 80
heart	96%	3990.19	827 / 861	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0000398	Biological process	mRNA splicing, via spliceosome
GO_0043484	Biological process	regulation of RNA splicing
GO_0006396	Biological process	RNA processing
GO_0071013	Cellular component	catalytic step 2 spliceosome
GO_0005654	Cellular component	nucleoplasm
GO_0005829	Cellular component	cytosol
GO_1990904	Cellular component	ribonucleoprotein complex
GO_0045202	Cellular component	synapse
GO_0005886	Cellular component	plasma membrane
GO_0016020	Cellular component	membrane
GO_0005634	Cellular component	nucleus
GO_0005515	Molecular function	protein binding
GO_0003727	Molecular function	single-stranded RNA binding
GO_0003723	Molecular function	RNA binding

IV. Literature review

[source]

Gene name	HNRNPF
Protein name	Heterogeneous nuclear ribonucleoprotein F (hnRNP F) (Nucleolin-like protein mcs94-1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein F, N-terminally processed] Heterogeneous nuclear ribonucleoprotein F
Synonyms	HNRPF
Description	FUNCTION: Component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes which provide the substrate for the processing events that pre-mRNAs undergo before becoming functional, translatable mRNAs in the cytoplasm. Plays a role in the regulation of alternative splicing events. Binds G-rich sequences in pre-mRNAs and keeps target RNA in an unfolded state. . FUNCTION: Component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes which provide the substrate for the processing events that pre-mRNAs undergo before becoming functional, translatable mRNAs in the cytoplasm. Plays a role in the regulation of alternative splicing events. Binds G-rich sequences in pre-mRNAs and keeps target RNA in an unfolded state. .
Accessions	ENST00000443950.6 ENST00000357065.8 ENST00000477108.5 ENST00000356053.7 ENST00000337970.7 ENST00000682386.1 ENST00000544000.5 A0A1B0GW42 P52597

HNRNPF report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review